Complete enrollment in the METEORIC-HF Phase 3 trial
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- 15 Jun 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Expect enrollment in METEORIC-HF to be completed in 1H 2021.”
What we found
Evidence strength A What the grades mean
The filings show METEORIC-HF enrollment was completed and announced on June 15, 2021, before the June 30, 2021 deadline.
-
A Cytokinetics Inc. 10-Q filed 2021-08-06
“On June 15, 2021 we announced that patient enrollment had been completed for METEORIC-HF.” ✓ confirmed on the page
-
A Cytokinetics Inc. 10-K filed 2022-02-25
“The trial completed enrollment of 276 patients in June 2021.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- Completed enrollment in METEORIC-HF
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Cytokinetics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CYTK-024465 · Corrections policy